Barings’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,900
Closed -$858K 971
2017
Q3
$858K Buy
+19,900
New +$946K 0.02% 522
2016
Q3
Sell
-8,800
Closed -$637K 866
2016
Q2
$637K Hold
8,800
0.02% 599
2016
Q1
$569K Sell
8,800
-40,600
-82% -$2.69M 0.02% 638
2015
Q4
$3.54M Buy
49,400
+17,700
+56% +$1.31M 0.09% 153
2015
Q3
$2.43M Buy
31,700
+8,600
+37% +$694K 0.06% 241
2015
Q2
$1.71M Buy
23,100
+19,300
+508% +$1.39M 0.05% 355
2015
Q1
$276K Hold
3,800
0.01% 835
2014
Q4
$251K Hold
3,800
0.01% 838
2014
Q3
$208K Hold
3,800
﹤0.01% 903
2014
Q2
$221K Hold
3,800
0.01% 908
2014
Q1
$236K Hold
3,800
0.01% 845
2013
Q4
$203K Buy
+3,800
New +$204K 0.01% 875

Other funds holding MD

Barings's MD Position: Q4 2017 in Review

Barings sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 19,900 shares — an estimated $858K sold.

Barings first reported a position in MD in Q4 2013 and held it in 12 quarters. The position peaked at $3.54M in Q4 2015. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • Barings reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
  • Barings sold 19,900 Pediatrix Medical shares in Q4 2017, an estimated $858K.
  • Barings first reported a position in Pediatrix Medical in Q4 2013 and held it in 12 quarters.
  • Barings's Pediatrix Medical position peaked at $3.54M in Q4 2015.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Barings's 13F filing for Q4 2017, filed 8 Feb 2018.